On the legal consciousness of internationalization

  • Detail

Talking about the consciousness of "laws and regulations" in the internationalization of traditional Chinese medicine packaging

in response to General Secretary Jiang Zemin's "carrying forward national culture and revitalizing the cause of traditional Chinese medicine." The Ministry of health, China Administration of traditional Chinese medicine and other nine central ministries and commissions jointly carried out the research on the subject of "developing and researching modern traditional Chinese medicine and promoting traditional Chinese medicine to the world". The author gives his opinion on one of his subjects, "the legal consciousness of the internationalization of traditional Chinese medicine packaging". According to the international business daily, the health department of Canada has formulated a series of regulations, such as the food and drug safety management act and the drug identification number management act, to strengthen the management of Chinese herbal medicine and its products. The key points are: any product with therapeutic effect should be treated as a drug. Any product that does not meet the health standards is not allowed to be listed. All Chinese herbal medicine products must apply for a drug license from the Canadian Department of health, that is, a drug identification number management license. The implementation of these laws and regulations has had a certain impact on the sales of Chinese traditional medicine in the Canadian market. Most Chinese medicine dealers in Canada may give up their Chinese medicine business because of the complicated application procedures and high fees. The reason is that Canada has strict laws and regulations, and the identification number needs to be clear. Therefore, in order for traditional Chinese medicine to enter the international market, we must improve the awareness of international laws and regulations of traditional Chinese medicine packaging. The United States Department of Agriculture recently made new regulations on the packaging of all products imported from China, including Chinese herbal medicine. All pure wood packaging materials must be subject to high-temperature fumigation or preservative treatment, otherwise all incoming goods will be refused entry. Germany has stricter regulations on wood packaging, which stipulates that all imported products are not allowed to use wood packaging. The US FDA, namely the US Food and drug administration, has formulated corresponding regulations for all links of drug sales, and stipulated that all drug-related materials should be subject to clinical scientific testing. The drug label must not only include the use of the drug, precautions for use by special groups (such as children, pregnant women, etc.), dose description, use method and time, but also indicate the side effects, contraindications and efficacy of the drug. Any label that does not meet the specified requirements is recognized as a "false label", which is a serious violation of federal law. In order to advertise drugs or provide relevant publicity materials, the contents must be exactly the same as those of the label, and there must be no other materials without approval or beyond the scope of the label. In addition, the packaging of exported traditional Chinese medicine must comply with the relevant laws or regulations of the importing country and region. Singapore lists Coptis chinensis and Aconitum Aconitum as toxic drugs, and the import of Chinese patent medicines containing these ingredients is prohibited; For traditional Chinese medicine containing lead, the content of lead must be less than 15ppm, and the content of aluminum must be less than 20ppm. The United States also prohibits the import and sale of Chinese patent medicines containing cinnabar, mercury, arsenic and other heavy metals. Therefore, Chinese medicine exported to these countries must meet the requirements of importing countries, and violators can only cause losses. For example, China × The Zhibao sanbian liquor exported from Hunan Province to Singapore has been tested by the health department of Singapore, and the mercury content is 0.85 μ g. 0.35 more than the national regulations μ G standard, so that the best-selling sanbian wine in the country for 20 years will be completely ruined. Although customs and habits are not laws and regulations, customs and habits must be regarded as "laws and regulations" in the export of traditional Chinese medicine. Japan regards "four" as "death", which is unlucky. Traditional Chinese medicine sold to Japan cannot be packed in 4 pills, 4 boxes or 4 bags. The cold compress ointment sold in Korea to Japan avoids the word "4" and is packed in "6" films, which is very popular. For the Chinese medicinal materials we sell to Africa and near the Middle East, 40kg per piece is appropriate, because there is manual loading and unloading. The goods exported to Southeast Asia should be 20-30kg each, which can only be used when exporting traditional Chinese medicine. Although psychology and customs are not "laws and regulations", they should not be taken lightly. Red crowned cranes and peacocks mean good luck and longevity in China, but in some areas they are regarded as prostitutes and fools. If traditional Chinese medicine is sold there, peacocks and red crowned cranes cannot be used as packaging patterns. The same colors are white, apricot yellow, dark blue or Tibetan orchid, which are endowed with different meanings and contents by different regions and nationalities. The coloring and drawing of traditional Chinese medicine packaging is also a major event that cannot be underestimated, and can be understood at the same price as the "Regulations". Targeted and targeted are also "Regulations" that are not regulations in the internationalization of TCM packaging. For example, cartons have become the mainstream in the internationalization of product packaging and traditional Chinese medicine packaging in various countries because of their lightness, low price, easy production and recycling. However, as the packaging of export commodities, we should also proceed from reality. The "heiqi" exported from Shanxi to Singapore has been made in wooden cases for decades, otherwise the customer thinks it is unsafe and the quality is unreliable. The order of packaging is from high to low, and the customer will return it. In the process of internationalization of traditional Chinese medicine packaging, we should always follow the general international law. As we all know, traditional Chinese medicine consists of three forms: Traditional Chinese medicine, decoction pieces and Chinese patent medicine. The difference between traditional Chinese medicine and decoction pieces is that the toxic and side effects are quite different after processing. The Chinese patent medicine made from decoction pieces according to the prescription is the summary of clinical verification for many years. Of course, the use of patients should be clearly explained without ambiguity or confusion. According to the Shennong herbal classic, "it is the three poisons of drugs that enhance the overall innovation level and competitiveness of the graphene industry chain", while the Chinese Pharmacopoeia defines the different toxicity of various traditional Chinese medicines. It is not difficult to imagine that China, as the world's first country in the intellectual property rights of traditional Chinese medicine, exports Chinese medicinal materials, prepared slices and proprietary Chinese medicines to hundreds of different countries and regions, "How important it is to make full use of the intellectual resources of academicians and experts of the Chinese Academy of engineering for the internationalization of packaging! It is gratifying and fortunate that on October 15, 2000, the State Drug Administration issued the regulations on the administration of drug packaging labels and instructions (Provisional) There are 18 articles in total, which will undoubtedly play a great role in promoting the standardization and standardization of China's drug packaging sales. We must earnestly implement them and work hard to raise China's internationalization of traditional Chinese medicine to a new level. (Chinese pharmaceutical market)

Copyright © 2011 JIN SHI